Related Experiment Video
Updated: Feb 16, 2026
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Identifying key regulating miRNAs in hepatocellular carcinomas by an omics' method
1The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P.R. China.
Abstract:
The miRNAs play important regulating roles in the pathogenesis of hepatocellular carcinoma (HCC). To uncover key regulating miRNAs in HCC that were neglected by traditional analyzing methods of transcriptomics data, we proposed a novel molecular-network-based omics' (MNBO) method. With this method, we predicted HCC-regulating miRNAs, and confirmed the role of a novel miR-590-3P/EED axis by a clinical study and in vitro, in vivo wet-experiments. The miR-590-3P is significantly down-regulated in HCC patients. And low level of miR-590-3P in HCC is associated with poor prognosis of patients. In HCC cell lines, the miR-590-3P suppressed cell proliferation by inhibiting the transformation G1 phase to S phases of the cell cycle. Moreover, the miR-590-3P inhibited migration and invasion of HCC cells. Further investigations indicated that miR-590-3P play its roles by inhibiting polycomb protein EED. The experiments in animal model implied miR-590-3P could be a potential therapeutic agent for HCC in the future. In conclusion, the discovery of miR-590-3P revealed the MNBO would be a useful strategy to uncover key regulating miRNAs in HCC.
Insights
A novel method identified miR-590-3P as a key regulator in hepatocellular carcinoma (HCC). This microRNA suppresses tumor growth and spread by targeting the EED protein, offering potential therapeutic strategies for HCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial in hepatocellular carcinoma (HCC) pathogenesis.
- Traditional transcriptomics methods may overlook key regulatory miRNAs in HCC.
- A novel molecular-network-based omics (MNBO) approach is proposed to address this gap.
Purpose of the Study:
- To identify novel, key regulatory miRNAs in hepatocellular carcinoma (HCC) using a new MNBO method.
- To elucidate the functional role and mechanism of a newly identified miRNA in HCC progression.
- To validate the therapeutic potential of the identified miRNA in preclinical models.
Main Methods:
- Development and application of a novel molecular-network-based omics (MNBO) method for miRNA discovery.
- Clinical data analysis to correlate miRNA expression with HCC patient prognosis.
- In vitro and in vivo experiments to assess the functional impact of miR-590-3P on HCC cells and tumor growth.
Main Results:
- The MNBO method successfully predicted key HCC-regulating miRNAs.
- A novel miR-590-3P/EED axis was identified and validated.
- miR-590-3P was found to be significantly downregulated in HCC, associated with poor prognosis.
- miR-590-3P suppressed HCC cell proliferation, cell cycle progression (G1 to S phase), migration, and invasion.
- miR-590-3P exerts its function by inhibiting the polycomb protein EED.
- Preclinical animal models suggest miR-590-3P as a potential HCC therapeutic agent.
Conclusions:
- The novel MNBO strategy is effective in uncovering critical regulatory miRNAs in HCC.
- The identified miR-590-3P/EED axis represents a significant finding in HCC pathogenesis.
- miR-590-3P demonstrates tumor-suppressive functions and holds promise as a future therapeutic target for HCC.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
02:39lncRNA - Long Non-coding RNAs